SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000891293-17-000057
Filing Date
2017-05-16
Accepted
2017-05-16 16:43:47
Documents
4
Period of Report
2017-05-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kagm.htm 8-K 62555
2 EXHIBIT 10.1 a1018-kagm.htm EX-10.1 140619
3 EXHIBIT 99.1 a9918-kagm.htm EX-99.1 6481
4 image0.jpg GRAPHIC 11087
  Complete submission text file 0000891293-17-000057.txt   221076
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-28386 | Film No.: 17849204
SIC: 2834 Pharmaceutical Preparations